Results 221 to 230 of about 751,159 (307)

LONG-TERM FOLLOW-UP AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE UNDER TACROLIMUS1

, 2000
Ashok Jain, Andrea F. DiMartini, Randeep Kashyap, Ada O. Youk, Susan Rohal, John J. Fung   +5 more
openalex   +1 more source

Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease. [PDF]

World J Gastroenterol
Durairajan SSK, Singh AK, Iyaswamy A.
europepmc   +1 more source

Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis

, 2000
Newton A C S Wong
openalex   +1 more source

Non-alcoholic fatty liver disease [PDF]

, 2017
Brent A. Neuschwander-Tetri
core   +1 more source

Causal relationships between the gut microbiota, inflammatory cytokines, and alcoholic liver disease: a Mendelian randomization analysis. [PDF]

Front Endocrinol (Lausanne)
Li S, Zhou C, Liu T, Zhang L, Liu S, Zhao Q, Liu J, Zhao W.   +7 more
europepmc   +1 more source

Alpinetin Exhibits Antioxidant and Anti-Inflammatory Effects in C57BL/6 Mice with Alcoholic Liver Disease Induced by the Lieber-DeCarli Ethanol Liquid Diet. [PDF]

Int J Mol Sci
Radosavljevic T, Brankovic M, Djuretić J, Grujic-Milanovic J, Kovacic M, Jevtic J, Stankovic S, Samardzic J, Vucevic D, Jakovljevic V.   +9 more
europepmc   +1 more source

Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study. [PDF]

BMC Public Health
Yoo JJ, Lee DH, Chang Y, Jo H, Cho YY, Lee S, Kim LY, Jang JY, Korean Association for the Study of the Liver.   +8 more
europepmc   +1 more source

Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease. [PDF]

World J Gastroenterol
Zhang H, Dong X, Zhu L, Tang FS.
europepmc   +1 more source

Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease <i>via</i> necroptosis-independent pathway. [PDF]

World J Gastroenterol
Xuan Yuan HN, Kim HS, Park GR, Ryu JE, Kim JE, Kang IY, Kim HY, Lee SM, Oh JH, Yoon EL, Jun DW.   +10 more
europepmc   +1 more source

Expression of lipopolysaccharide binding protein and its receptor CD14 in experimental alcoholic liver disease

, 2001
Guoqing Zuo
openalex   +1 more source